New scan could boost cure rates for rare thyroid cancer
NCT ID NCT07383246
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a special PET scan (68Ga-CTR-FAPI) can help surgeons remove all medullary thyroid cancer during the first surgery, aiming for a cure. About 150 newly diagnosed patients will be split into two groups: one gets surgery guided by the new scan, the other gets standard surgery chosen by their doctor. The main goal is to see if the scan-guided approach leads to more patients having undetectable cancer levels after surgery.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MEDULLARY THYROID CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
RECRUITINGBeijing, Beijing Municipality, 10005, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Massive database study probes link between popular diabetes drugs and rare thyroid cancer
- New imaging agent could improve detection of rare cancers
- New hope for advanced thyroid cancer: drug shows tumor-shrinking promise
- New radioactive therapy targets hard-to-treat thyroid cancer
- New hope for rare cancers? drug combo shows promise in early trial
- Thyroid cancer patients may spend less time in discomfort with simple phone calls